Thoracic Outlet Syndrome Market Research Report- Forecast to 2027

Thoracic Outlet Syndrome Market Research Report Information: By Type (Neurogenic, Venous, Arterial Thoracic Outlet Syndrome) Diagnosis (Ct Scan, Mri Scan, Blood Tests, Arteriogram), Treatment (Surgery, Medication), End-User- Forecast Till 2027

ID: MRFR/MED/4100-HCR | February 2021 | Region: Global | 85 pages

Thoracic Outlet Syndrome Market Scenario


Thoracic outlet syndrome is a group of heterogeneous and disabling upper-extremity disorders that occur due to extrinsic compression of neurovascular structures between the clavicle and the first rib. There are three distinct types of thoracic outlet syndrome viz. neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome. Neurogenic thoracic outlet syndrome is most common, i.e., it constitutes around 85%-90% of thoracic outlet syndrome cases. Venous thoracic outlet syndrome constitutes around 10%-15% of thoracic outlet syndrome cases, whereas arterial thoracic outlet syndrome is found in 2%-5% of thoracic outlet syndrome cases.


Rising cases of trauma and car accidents are boosting the growth of the thoracic outlet syndrome market. Chest injury is one of the causes of thoracic outlet syndrome, and this comes about as a result of traffic accidents in which the collarbone is broken, and the upper ribs are injured. As per the World Health Organization (WHO) report, nearly 20-50 million people incur non-fatal injuries as a result of road traffic accidents.


Other factors such as increasing cases of anatomical defects, high unmet needs of current treatment, and surge in the research and development expenditure, improvement in reimbursement policies are also expected to drive the growth of the market. According to a study published in the Current Issues in Pharmacy and Medical Sciences - De Gruyter journal in 2015, it is found that bone abnormality may be a potential cause of thoracic outlet syndrome. The most common bone abnormalities include irregularities of the clavicle (20%), the cervical rib (70% of cases), and in the different structures of the first rib (10%).


Despite these drivers, there are some issues associated with thoracic outlet syndrome market. Lack of infrastructure in the middle and low-income countries and side effects associated with the drugs may hamper the growth of the market.


It is estimated that thoracic outlet syndrome market is expected to grow at a CAGR 7.0% during the forecast period of 2017-2023.


Research Methodology


 Thoracic Outlet Syndrome


Sources: Annual reports, Press release, White paper, and Company presentation


Thoracic Outlet Syndrome MarketSegmentation


The thoracic outlet syndrome market is segmented on the basis of type, diagnosis, treatment, and end-user.


On the basis of type, the market Thoracic Outlet Syndrome Marketis segmented into neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.


On the basis of diagnosis, the market is segmented into nerve conduction studies, vascular studies, chest X-ray, cervical spine X-rays, computed tomography (CT) scan, magnetic resonance imaging (MRI), and magnetic resonance imaging with angiography (MRA), arteriogram/venogram, and blood tests.


On the basis of treatment, the market is segmented into surgery, medications, physical therapy, and others. The medications segment is further classified into muscle relaxant, thrombolytic medications, anticoagulant medications, and others.


On the basis of end-user, the market is segmented into hospital & Clinics, diagnostic centers, academic and research institutes, drug pharmacies, and others.


Thoracic Outlet Syndrome Market Regional Analysis


The Americas dominate the thoracic outlet syndrome market owing to the rising awareness among people, and increasing healthcare expenditure. As per the facts suggested by the Centers for Disease Control and Prevention (CDC), out of the total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States.


Europe holds the second position in the thoracic outlet syndrome market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe.


Asia Pacific is the fastest growing in thoracic outlet syndrome market, owing to a huge patient pool, developing healthcare technology, and rising healthcare expenditure in some countries within this region. According to the Australian Institute of Health and Welfare, in the years 2015 to 2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014–15.


The Middle East & Africa has the lowest market for thoracic outlet syndrome due to lack of technical knowledge and poor medical facilities.


Thoracic Outlet Syndrome Market Key Players


Some of key the players in the market are Abbott Laboratories, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Mallinckrodt plc., Orient Pharma Co., Ltd., Par Sterile Products, LLC., Sanofi, SteriMax Inc., Upsher Smith Laboratories, Inc., Vertical Pharmaceuticals LLC, and others.


Intended Audience



  • Hospitals

  • Diagnostic Clinics

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   2017-2023: 7.0%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Diagnosis, Treatment, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Mallinckrodt plc., Orient Pharma Co., Ltd., Par Sterile Products, LLC., Sanofi, SteriMax Inc., Upsher Smith Laboratories, Inc., Vertical Pharmaceuticals LLC, and others
  Key Market Opportunities

  • Owing to a huge patient pool
  • Developing healthcare technology
  • Rising healthcare expenditure
  •   Key Market Drivers

  • Increasing cases of anatomical defects
  • High unmet needs of current treatment
  • Surge in the research and development expenditure
  • Improvement in reimbursement policies


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Thoracic outlet syndrome market CAGR would be 7% during the forecast period.

    North America would dominate the thoracic outlet syndrome market.

    The treatment types discussed in the thoracic outlet syndrome market report are medications, physical therapy, surgery, and others.

    Europe is the second-largest thoracic outlet syndrome market region.

    The players discussed in the thoracic outlet syndrome market are Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Abbott Laboratories, Upsher Smith Laboratories, Inc., Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Daiichi Sankyo, Orient Pharma Co., Ltd., Par Sterile Products, LLC., Mallinckrodt plc., SteriMax Inc., Sanofi, Vertical Pharmaceuticals LLC, and others.

    Table Of Contents:


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope Of The Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power Of Suppliers

    5.1.2 Bargaining Power Of Buyers

    5.1.3 Threat Of New Entrants

    5.1.4 Threat Of Substitutes

    5.1.5 Intensity Of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Thoracic Outlet Syndrome Market, By Type

    6.1 Introduction

    6.2 Neurogenic Thoracic Outlet Syndrome

    6.2.1 Market Estimates & Forecast, 2020 – 2027

    6.3 Venous Thoracic Outlet Syndrome

    6.3.1 Market Estimates & Forecast, 2020 – 2027

    6.4 Arterial Thoracic Outlet Syndrome

    6.4.1 Market Estimates & Forecast, 2020 – 2027

    Chapter 7. Global Thoracic Outlet Syndrome Market, By Diagnosis

    7.1 Introduction

    7.2 Nerve Conduction Studies

    7.2.1 Market Estimates & Forecast, 2020 – 2027

    7.3 Vascular Studies

    7.3.1 Market Estimates & Forecast, 2020 – 2027

    7.4 Chest X-Ray

    7.4.1 Market Estimates & Forecast, 2020 – 2027

    7.5 Computed Tomography (CT) Scan

    7.5.1 Market Estimates & Forecast, 2020 – 2027

    7.6 Magnetic Resonance Imaging (MRI)

    7.6.1 Market Estimates & Forecast, 2020 – 2027

    7.7 Magnetic Resonance Imaging With Angiography (MRA)

    7.7.1 Market Estimates & Forecast, 2020 – 2027

    7.8 Arteriogram/Venogram

    7.8.1 Market Estimates & Forecast, 2020 – 2027

    7.9 Blood Tests

    7.9.1 Market Estimates & Forecast, 2020 – 2027 Chapter 8. Global Thoracic Outlet Syndrome Market, By Treatment

    8.1 Introduction

    8.2 Surgery

    8.2.1 Market Estimates & Forecast, 2018 – 2023

    8.3 Medications

    8.3.1 Market Estimates & Forecast, 2018 – 2023

    8.4 Physical Therapy

    8.4.1 Market Estimates & Forecast, 2018 – 2023

    8.5 Others

    8.5.1 Market Estimates & Forecast, 2018 – 2023 Chapter 9. Global Thoracic Outlet Syndrome Market, By End User

    9.1 Introduction

    9.2 Hospital & Clinics

    9.2.1 Market Estimates & Forecast, 2020 – 2027

    9.3 Diagnostic Centers

    9.3.2 Market Estimates & Forecast, 2020 – 2027

    9.4 Academic And Research Institutes

    9.4.1 Market Estimates & Forecast, 2020 – 2027

    9.5 Others

    9.5.2 Market Estimates & Forecast, 2020 – 2027

    Chapter 10. Global Thoracic Outlet Syndrome Market, By Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 U.K

    10.3.1.6 Rest Of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic Of Korea

    10.4.6 Rest Of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest Of The Middle East & Africa

    Chapter 10 Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    Chapter 11 Company Profiles

    11.1 Abbott Laboratories

    11.1.1 Company Overview

    11.1.2 Types Overview

    11.1.3 Financials

    11.1.4 SWOT Analysis

    11.2 Bayer AG

    11.2.1 Company Overview

    11.2.2 Types Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Boehringer Ingelheim

    11.3.1 Company Overview

    11.3.2 Types Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Johnson & Johnson Services, Inc.

    11.4.1 Company Overview

    11.4.2 Types/Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Sanofi

    11.5.1 Company Overview

    11.5.2 Types Overview

    11.5.3 Financial Overview

    11.5.4 Key Developments

    11.6 Vertical Pharmaceuticals LLC

    11.6.1 Company Overview

    11.6.2 Types Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.7 DAIICHI SANKYO

    11.7.1 Overview

    11.7.2 Types Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Others

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs Of The Market

    12.2 Key Companies To Watch

    12.3 Prediction Of Thoracic Outlet Syndrome Industry

    Chapter 13 Appendix LIST OF TABLES

    Table 1 Thoracic Outlet Syndrome Industry Synopsis, 2020 – 2027

    Table 2 Thoracic Outlet Syndrome Market Estimates And Forecast, 2020 – 2027, (USD Million)

    Table 3 Thoracic Outlet Syndrome Market By Region, 2020 – 2027, (USD Million)

    Table 4 Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

    Table 5 Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 6 Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 7 Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 8 North America Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

    Table 9 North America Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 10 North America Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 11 North America Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 12 US Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

    Table 13 US Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 14 US Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 15 US Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 16 Canada Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

    Table 17 Canada Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 18 Canada Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 19 Canada Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 20 South America Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

    Table 21 South America Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 22 South America Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 23 South America Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 24 Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

    Table 25 Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 26 Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 27 Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 28 Western Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

    Table 29 Western Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 30 Western Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 31 Western Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 32 Eastern Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

    Table 33 Eastern Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 34 Eastern Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 35 Eastern Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 36 Asia Pacific Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

    Table 37 Asia Pacific Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 38 Asia Pacific Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 39 Asia Pacific Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 40 Middle East & Africa Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

    Table 41 Middle East & Africa Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 42 Middle East & Africa Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 43 Middle East & Africa Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

    LIST OF FIGURES Figure 1 Research Process

    Figure 2 Segmentation For Thoracic Outlet Syndrome Market

    Figure 3 Segmentation Market Dynamics For Thoracic Outlet Syndrome Market

    Figure 4 Global Thoracic Outlet Syndrome Market Share, By Type 2020

    Figure 5 Global Thoracic Outlet Syndrome Market Share, By Diagnosis 2020

    Figure 6 Global Thoracic Outlet Syndrome Market Share, By Treatment 2020

    Figure 7 Global Thoracic Outlet Syndrome Market Share, By End Users, 2020

    Figure 8 Global Thoracic Outlet Syndrome Market Share, By Region, 2020

    Figure 9 North America Thoracic Outlet Syndrome Market Share, By Country, 2020

    Figure 10 Europe Thoracic Outlet Syndrome Market Share, By Country, 2020

    Figure 11 Asia Pacific Thoracic Outlet Syndrome Market Share, By Country, 2020

    Figure 12 Middle East & Africa Thoracic Outlet Syndrome Market Share, By Country, 2020

    Figure 13 Global Thoracic Outlet Syndrome Market: Company Share Analysis, 2020 (%)

    Figure 14 Abbott Laboratories: Key Financials

    Figure 15 Abbott Laboratories Segmental Revenue

    Figure 16 Abbott Laboratories: Geographical Revenue

    Figure 17 Bayer AG: Key Financials

    Figure 18 Bayer AG: Segmental Revenue

    Figure 19 Bayer AG: Geographical Revenue

    Figure 20 Boehringer Ingelheim: Key Financials

    Figure 21 Boehringer Ingelheim: Segmental Revenue

    Figure 22 Boehringer Ingelheim: Geographical Revenue

    Figure 23 Johnson & Johnson Services, Inc.: Key Financials

    Figure 24 Johnson & Johnson Services, Inc.: Segmental Revenue

    Figure 25 Johnson & Johnson Services, Inc.: Geographical Revenue

    Figure 26 Sanofi: Key Financials

    Figure 27 Sanofi: Segmental Revenue

    Figure 28 Sanofi Geographical Revenue

    Figure 29 Vertical Pharmaceuticals LLC: Key Financials

    Figure 30 Vertical Pharmaceuticals LLC: Segmental Revenue

    Figure 31 Vertical Pharmaceuticals LLC: Geographical Revenue

    Figure 32 DAIICHI SANKYO: Key Financials

    Figure 33 DAIICHI SANKYO: Segmental Revenue

    Figure 34 DAIICHI SANKYO: Geographical Revenue

    Bottom of Form